Seminars in Nephrology
Volume 29, Issue 6 , Pages 604-609 , November 2009

Hypertension and its Management in the Elderly

  • Basil O. Burney, MD
    • ,
  • George L. Bakris, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to George Bakris, MD, Department of Medicine, Hypertensive Diseases Unit, University of Chicago School of Medicine, 5841 S. Maryland Ave, MC 1027, Room P-328, Chicago, IL 60637

References 

  1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913
  2. Weber MA. Exploring a new definition of hypertension. Rev Cardiovasc Med. 2005;6:164–172
  3. Ostchega Y, Dillon CF, Hughes JP, Carroll M, Yoon S. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc. 2007;55:1056–1065
  4. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  5. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. 2002;162:577–581
  6. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure (The Framingham Heart Study). Circulation. 1997;96:308–315
  7. Phillips PA, Hodsman GP, Johnston CI. Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly. Cardiovasc Drugs Ther. 1991;4(Suppl 6):1209–1213
  8. Campese VM. Salt sensitivity in hypertension (Renal and cardiovascular implications). Hypertension. 1994;23:531–550
  9. Zemel MB, Sowers JR. Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol. 1988;61:7H–12H
  10. Messerli FH, Kupfer S, Pepine CJ. J curve in hypertension and coronary artery disease. Am J Cardiol. 2005;95:160
  11. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension (Final results of the Systolic Hypertension in the Elderly Program (SHEP)). JAMA. 1991;265:3255–3264
  12. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?. Ann Intern Med. 2006;144:884–893
  13. Stevens JC. Detection of tastes in mixture with other tastes: issues of masking and aging. Chem Senses. 1996;21:211–221
  14. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE) (TONE Collaborative Research Group). JAMA. 1998;279:839–846
  15. de Leeuw PW. Nonsteroidal anti-inflammatory drugs and hypertension (The risks in perspective). Drugs. 1996;51:179–187
  16. Johnson AG. NSAIDs and increased blood pressure (What is the clinical significance?). Drug Saf. 1997;17:277–289
  17. Whelton A, Schulman G, Wallemark C, et al. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med. 2000;160:1465–1470
  18. Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121–1123
  19. Perry HM, Davis BR, Price TR, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000;284:465–471
  20. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898
  21. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997
  22. Wing LM, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med. 2003;348:583–592

PII: S0270-9295(09)00148-X

doi: 10.1016/j.semnephrol.2009.07.005

Seminars in Nephrology
Volume 29, Issue 6 , Pages 604-609 , November 2009

Article Tools

* Image Usage & Resolution